John P. Bilezikian, MD

Professor of Medicine and Pharmacology
College of Physicians and Surgeons
Columbia University
Chief, Division of Endocrinology
Director, Metabolic Bone Diseases Program
Columbia-Presbyterian Medical Center
New York, New York

John P. Bilezikian, MD is professor of medicine and pharmacology at the College of Physicians and Surgeons, Columbia University, in New York. He also is chief of the Division of Endocrinology, and director of the Metabolic Bone Diseases Program at Columbia-Presbyterian Medical Center in New York City.

Dr. Bilezikian earned his undergraduate degree in biochemistry from Harvard College in Cambridge, Mass., and medical degree from the College of Physicians and Surgeons at Columbia University. He completed his internship and served as chief resident at Columbia-Presbyterian Medical Center. Training in metabolic bone disease and endocrinology was completed at the National Institutes of Health (NIH), under the tutelage of Gerald D. Aurbach, MD, where Dr. Bilezikian served as clinical associate in the branch of mineral metabolism.

Dr. Bilezikian is the former president and a current member of both The International Society of Clinical Densitometry (1999-2001), and The American Society for Bone and Mineral Research (1995-1996). He has been designated master by the American College of Endocrinology, and also is a member of The American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, and the American Society for Pharmacology and Experimental Therapeutics.

Dr. Bilezikian is editor-in-chief of the Journal of Clinical Endocrinology & Metabolism. He also is editor-in-chief of the book titled The Parathyroids (1994, 2001); and co-editor of Principles of Bone Biology (1996, 2002), The Aging Skeleton (1999), and Dynamics of Bone and Cartilage Metabolism (1999). During the course of his professional career, Dr. Bilezikian has authored more than 425 publications which reflect his investigative initiatives and interest in endocrinology and metabolic bone diseases.

Recognized both nationally and internationally as a spokesperson in the field of metabolic bone diseases, Dr. Bilezikian has served on numerous panels and has received many awards. He has been the chair (1994) for the National Institutes of Health (NIH) Consensus Development Panel on Optimal Calcium Intake, and co-chair (2002) of the NIH Workshop on Primary Hyperparathyroidism. He also is the recipient of the Distinguished Physician Award of The Endocrine Society, and of the Frederic C. Bartter Award of The American Society for Bone and Mineral Research for excellence in clinical research.

His major research interests include clinical investigation of metabolic bone diseases, in particular, osteoporosis and primary hyperparathyroidism, and biochemical mechanisms of the hormones that regulate calcium metabolism.